Background illustration for clinical trials search

Paid Clinical Trials Everett

Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

for
Neuroendocrine Tumors Unresectable,
Location: Seattle WA, Omaha NE, Rochester MN, Iowa City IA,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05636618

Phase 1, Phase 2, Recruiting

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer
Location: Seattle WA, San Francisco CA, Murray UT, Duarte CA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT04221542

Phase 1, Recruiting

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

for
Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia,
Location: Seattle WA, Houston TX, Cincinnati OH, Nashville TN,
Sponsor: Vincerx Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06034275

Phase 1, Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: Seattle WA, Los Angeles CA, Duarte CA, San Diego CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06625775

Phase 1, Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for
Solid Tumor
Location: Seattle WA, Westwood KS, Iowa City IA, Houston TX,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

for
Prostate Cancer
Location: Seattle WA, San Francisco CA, Milwaukee WI, St Louis MO,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT06613100

Phase 1, Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

for
Acute Leukemia, Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0+

Code: NCT04195633

Phase 2, Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Seattle WA, Sacramento CA, San Francisco CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06917079

Phase 1, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Seattle WA, Tacoma WA, Eugene OR, Edmonton,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase 1, Recruiting

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Seattle WA, Phoenix AZ, Rochester MN, Chicago IL,
Sponsor: Chordia Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05732103

Phase 1, Phase 2, Recruiting

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Seattle WA, St Louis MO, Chapel Hill NC
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06179303

Phase 2, Recruiting

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

for
Castration Resistant Metastatic Prostate Cancer
Location: Seattle WA, San Diego CA, Omaha NE, Minneapolis MN,
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male

Age: 18 - 70+

Code: NCT04363164

Phase 2, Recruiting

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Seattle WA, Salt Lake City UT, Colorado Springs CO,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05413421

Phase 1, Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Seattle WA, Las Vegas NV, Duarte CA, Orange CA,
Sponsor: J-Pharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT07265674

Phase 3, Recruiting

Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

for
Myelodysplastic/Myeloproliferative Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT07228624

Phase 2, Recruiting

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

for
Chronic Lung Disease, Hematopoietic Cell Transplantation,
Location: Seattle WA, Stanford CA, Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 3+

Code: NCT05866302

Recruiting

Sustained Oral Fiber Supplementation for Patients Undergoing Treatment for Hematological Malignancies

for
Hematopoietic and Lymphatic System Neoplasm
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT04829136

Recruiting

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

for
Metastatic Castration-Resistant Prostate Carcinoma,
Location: Seattle WA, San Francisco CA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT06526299

Phase 2, Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

for
Triple Negative Breast Cancer, Breast Cancer,
Location: Seattle WA, Spokane WA, San Francisco CA,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05377996

Phase 1, Phase 2, Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Englewood CO,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting